FIELD: medicine, in particular virology.
SUBSTANCE: claimed method includes subcutaneous administration of Hantaan virus strain 76-118 to white mouse in dose of 10 LD50.
EFFECT: method for symptomless in vivo studying of antiviral drug effectiveness in regard to Hantaan virus.
1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL MEDICATION AND METHOD OF PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2010 |
|
RU2457844C2 |
| FENCHONE N-ACYLHYDRAZONE WITH AN EPOXY ISOINDOLE FRAGMENT USED AS AN INHIBITOR OF HANTAAN VIRUS REPRODUCTION | 2020 |
|
RU2733472C1 |
| METHOD OF CHANTA-VIRUS DIAGNOSTICUM PREPARING | 2000 |
|
RU2180754C2 |
| METHOD FOR PREDICTION OF SEVERE HAEMORRHAGIC FEVER WITH RENAL SYNDROME AT EARLY STAGES OF DISEASE | 2022 |
|
RU2790962C1 |
| METHOD FOR PREPARING COMBINED BIVALENT, TISSUE-CULTURE, INACTIVATED, CONCENTRATED, PURIFIED VACCINE FOR PREVENTING HEMORRHAGIC FEVER AND RENAL SYNDROME | 2009 |
|
RU2445117C2 |
| AGENT POSSESSING ANTIVIRAL ACTIVITY | 2006 |
|
RU2304443C1 |
| VIRUS STRAIN FOR PRODUCING VACCINE DRUGS AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME (OPTIONS) | 2018 |
|
RU2683508C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS | 2010 |
|
RU2450274C1 |
| STRAIN C/2014 OF MACHUPO VIRUS - AGENT OF BOLIVIAN HAEMORRHAGIC FEVER INTENDED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICAL REMEDIES IN RESPECT OF THIS PATHOGEN | 2017 |
|
RU2699525C2 |
| METHOD FOR PRODUCING CULTURAL, POLYVALENT EPIDEMIC HAEMORRHAGIC FEVER DIAGNOSTICUM FOR INDIRECT IMMUNOFLUORESCENCE | 2010 |
|
RU2431148C1 |
